Funding Rounds
APIM Therapeutics

APIM Therapeutics Unknown (2019, $0M)

APIM Therapeutics

Proprietary peptide drug development targeting PCNA (Proliferating Cell Nuclear Antigen).

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Unknown

Raised Amount: $0.00M

Raised Date: 2019-01-01

Investors